Home › Endo to pay $25M for nasal testosterone replacement therapy
 

Keywords :   


Endo to pay $25M for nasal testosterone replacement therapy

2014-11-25 00:20:24| Biotech - Topix.net

Endo International made a bigger push into the testosterone replacement therapy market Monday by agreeing to acquire the rights to Natesto for $25 million. Natesto is the only testosterone nasal gel approved by the Food and Drug Administration as a replacement therapy for adult males with hypogonadism - a condition where sex glands produce little or no sex hormones.

Tags: pay therapy replacement 25m

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
22.11ONE PIECE 1109
22.1190old
22.11SHIMANO
22.11Hi-STANDARD growing up
22.1111th ANNIVERSARY SPECIAL SET
22.11 3
22.11
22.11MSR LIGHTNING ASCENT25
More »